• LAST PRICE
    16.3600
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 16.3600
  • Day Range
    ---
  • 52 Week Range
    Low 7.8600
    High 17.4300
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 16.54
TimeVolumeDHT.UN
09:32 ET260016.5
09:34 ET20016.43
09:36 ET10016.39
10:01 ET60016.35
10:03 ET100016.38
10:08 ET50016.4
10:15 ET40016.34
10:17 ET10016.37
10:19 ET10016.39
10:51 ET10016.41
11:11 ET10016.41
11:15 ET30016.35
11:22 ET30016.35
11:26 ET10016.36
11:36 ET20016.31
11:58 ET60016.35
12:27 ET10016.33
12:54 ET10016.32
01:08 ET70016.28
01:32 ET220016.22
01:55 ET40016.2
02:42 ET50016.16
03:07 ET30016.17
03:14 ET10016.2
03:18 ET180016.27
03:20 ET30016.28
03:21 ET10016.25
03:23 ET80016.24
03:27 ET10016.2
03:36 ET180016.28
03:43 ET20016.31
03:48 ET210016.34
03:50 ET20016.35
03:52 ET30016.35
03:59 ET40016.36
Data delayed at least 15 minutes.

Industry Peers

Company Information

DRI Healthcare Trust is a Canada-based company, which is engaged in providing financing to advance innovation in the life sciences industry. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It is acquiring approximately 70 royalties on 40-plus drugs, including Eylea, Spinraza, Zytiga, Remicade, Keytruda and Stelara. The Company’s portfolio includes Empaveli, Eylea, Natpara, Omidria, Rydapt, Simponi, Syfovre, Vonjo, Zejula and Zytiga. Its therapeutic areas include influenza, endocrinology, ophthalmology, dermatology, oncology, neurology, autoimmune diseases, heme-onc, lysosomal storage disorder, respiratory diseases, oncology and others. The Company is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Takeda; Galderma Laboratories; Novartis; Biogen; CTI Biopharma; Roche, Novartis, Johnson & Johnson, and others.

Contact Information

Headquarters
1 First Canadian Place Suite 7250, 100 King Street WestToronto, ON, Canada M5X 1B1
Phone
416-863-1865
Fax
---

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
---
Revenue (TTM)
---
Shares Outstanding
---
Dividend Yield
2.82%
Annual Dividend Rate
0.3400 USD
Ex-Dividend Date
03-27-24
Pay Date
04-19-24
Beta
---
EPS
---
Book Value
---
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.